Growth Metrics

Palisade Bio (PALI) Profit After Tax Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 33.04%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 30.60%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -154.28%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 13.80%
7 Evaxion A 62.56 Bn 62.54 Bn - 16.53%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -3.84%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 47.10%
10 Palisade Bio 439.25 Mn 309.68 Mn - -60.09%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -60.09%
Dec 31, 2025 -33.74%
Sep 30, 2025 10.43%
Jun 30, 2025 -5.90%
Mar 31, 2025 19.06%
Dec 31, 2024 -72.32%
Sep 30, 2024 -34.46%
Jun 30, 2024 49.53%
Mar 31, 2024 4.35%
Dec 31, 2023 11.21%
Sep 30, 2023 -24.96%
Jun 30, 2023 -22.38%
Mar 31, 2023 0.62%
Dec 31, 2022 -22.22%
Sep 30, 2022 -31.30%
Jun 30, 2022 -17.72%
Mar 31, 2022 -10.53%
Dec 31, 2021 74.90%
Sep 30, 2021 85.84%
Jun 30, 2021 -269.94%
Mar 31, 2021 -23.36%
Dec 31, 2020 -8.58%
Sep 30, 2020 -139.72%
Jun 30, 2020 26.43%
Mar 31, 2020 31.96%
Dec 31, 2019 27.72%
Sep 30, 2019 30.36%
Jun 30, 2019 28.02%
Mar 31, 2019 22.17%
Dec 31, 2018 59.34%
Sep 30, 2018 31.27%
Jun 30, 2018 51.36%
Mar 31, 2018 24.82%
Dec 31, 2017 15.54%
Sep 30, 2017 68.92%
Jun 30, 2017 11.69%
Mar 31, 2017 -8.53%
Dec 31, 2016 -17.77%
Sep 30, 2016 7.92%
Jun 30, 2016 14.90%
Mar 31, 2016 -22.54%
Dec 31, 2015 -20.63%
Sep 30, 2015 -29.81%
Jun 30, 2015 -31.86%
Mar 31, 2015 -27.24%
Dec 31, 2014 -29.12%
Sep 30, 2014 -11.53%
Jun 30, 2014 -22.77%
Mar 31, 2014 -24.04%
Dec 31, 2013 -6.45%
Sep 30, 2013 -19.38%
Jun 30, 2013 -8.08%